201 related articles for article (PubMed ID: 19517779)
41. [Upper extremity botulinum toxin treatment in cerebral palsy. Treatment guidelines the first step towards national cooperation].
Arner M; Himmelmann K; Pontén E; Stankovic N; Hansson T; Dahlin LB
Lakartidningen; 2008 Oct 22-28; 105(43):3009-13. PubMed ID: 19024613
[No Abstract] [Full Text] [Related]
42. Costs and consequences of botulinum toxin type A use. Management of children with cerebral palsy in Germany.
Ruiz FJ; Guest JF; Lehmann A; Davie AM; Güttler K; Schlüter O; Dreiss G
Eur J Health Econ; 2004 Oct; 5(3):227-35. PubMed ID: 15714343
[TBL] [Abstract][Full Text] [Related]
43. The effects of quantitative gait assessment and botulinum toxin a on musculoskeletal surgery in children with cerebral palsy.
Molenaers G; Desloovere K; Fabry G; De Cock P
J Bone Joint Surg Am; 2006 Jan; 88(1):161-70. PubMed ID: 16391261
[TBL] [Abstract][Full Text] [Related]
44. Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review.
Park ES; Rha DW
Yonsei Med J; 2006 Oct; 47(5):589-603. PubMed ID: 17066503
[TBL] [Abstract][Full Text] [Related]
45. Outcomes of Botulinum Toxin Type A Injection Followed by Rehabilitation in Cases of Cerebral Palsy With Upper Extremity Involvement.
Karaca B; Ünlü E; Köse G; Gönen E; Çakcı A
J Child Neurol; 2016 Mar; 31(3):357-63. PubMed ID: 26239492
[TBL] [Abstract][Full Text] [Related]
46. Botulinum toxin A injections do not improve surface EMG patterns during gait in children with cerebral palsy--a randomized controlled study.
van der Houwen LE; Scholtes VA; Becher JG; Harlaar J
Gait Posture; 2011 Feb; 33(2):147-51. PubMed ID: 21190858
[TBL] [Abstract][Full Text] [Related]
47. Focal spasticity therapy with botulinum toxin: effects on function, activities of daily living and pain in 100 adult patients.
Bergfeldt U; Borg K; Kullander K; Julin P
J Rehabil Med; 2006 May; 38(3):166-71. PubMed ID: 16702083
[TBL] [Abstract][Full Text] [Related]
48. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
[TBL] [Abstract][Full Text] [Related]
49. [Botulinum toxin A in children with infantile cerebral palsy: indications and treatment concepts].
Placzek R
Orthopade; 2010 Jan; 39(1):23-30. PubMed ID: 20033394
[TBL] [Abstract][Full Text] [Related]
50. Potentiation of botulinum toxin type A with oral anti-spasticity medications in the management of focal spasticity.
Dai A
J Rehabil Med; 2007 Mar; 39(2):189; author reply 189. PubMed ID: 17351705
[No Abstract] [Full Text] [Related]
51. [Botulinum toxin treatment in children].
Sätilä H; Vähäsarja V; Paavilainen P
Duodecim; 2011; 127(22):2417-24. PubMed ID: 22238919
[TBL] [Abstract][Full Text] [Related]
52. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
[TBL] [Abstract][Full Text] [Related]
53. [Botulinum toxine treatment and the formation of antibodies to botulotoxin in patients with cerebral palsy].
Kenis VM; Baindurashvili AG; Dovbeshko AG; Korol'kova TN; Ivanov AM; Stepanova IuA; Protasov OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):48-51. PubMed ID: 22027670
[TBL] [Abstract][Full Text] [Related]
54. Tendon transfer surgery in upper-extremity cerebral palsy is more effective than botulinum toxin injections or regular, ongoing therapy.
Van Heest AE; Bagley A; Molitor F; James MA
J Bone Joint Surg Am; 2015 Apr; 97(7):529-36. PubMed ID: 25834076
[TBL] [Abstract][Full Text] [Related]
55. Effects of botulinum toxin type A and a programme of functional activity to improve manual ability in children and adolescents with cerebral palsy.
Rösblad B; Andersson G; Pettersson K
Scand J Plast Reconstr Surg Hand Surg; 2007; 41(5):250-8. PubMed ID: 17886127
[TBL] [Abstract][Full Text] [Related]
56. Does botulinum toxin prevent or promote deformity in children with cerebral palsy?
Gough M
Dev Med Child Neurol; 2009 Feb; 51(2):89-90. PubMed ID: 19191839
[No Abstract] [Full Text] [Related]
57. Botulinum toxin type A treatment in children with cerebral palsy: evaluation of treatment success or failure by means of goal attainment scaling.
Desloovere K; Schörkhuber V; Fagard K; Van Campenhout A; De Cat J; Pauwels P; Ortibus E; De Cock P; Molenaers G
Eur J Paediatr Neurol; 2012 May; 16(3):229-36. PubMed ID: 21843959
[TBL] [Abstract][Full Text] [Related]
58. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
Balbaloglu O; Basaran A; Ayoglu H
J Child Neurol; 2011 Apr; 26(4):482-7. PubMed ID: 21270468
[TBL] [Abstract][Full Text] [Related]
59. Sonography-guided injection of botulinum toxin A in children with cerebral palsy.
Berweck S; Feldkamp A; Francke A; Nehles J; Schwerin A; Heinen F
Neuropediatrics; 2002 Aug; 33(4):221-3. PubMed ID: 12368994
[TBL] [Abstract][Full Text] [Related]
60. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
Mirska A; Cybula K; Okurowska-Zawada B; Kułak W; Dmitruk E; Okulczyk K; Kalinowska AK
J Pediatr Orthop B; 2014 Nov; 23(6):517-22. PubMed ID: 25171568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
